BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Given Consensus Recommendation of “Hold” by Analysts
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) has earned an average recommendation of “Hold” from the six ratings firms that are presently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among […]
More Stories
StockNews.com Downgrades WPP (NYSE:WPP) to Hold
WPP (NYSE:WPP – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold”...
Canterra Minerals (CVE:CTM) Trading 5% Higher – Should You Buy?
Canterra Minerals Co. (CVE:CTM – Get Free Report)’s share price traded up 5% during trading on Monday . The company...
Johnson Controls International plc (NYSE:JCI) Short Interest Down 13.0% in October
Johnson Controls International plc (NYSE:JCI – Get Free Report) saw a large decrease in short interest in the month of...
Short Interest in Grindr Inc. (NYSE:GRND) Expands By 12.3%
Grindr Inc. (NYSE:GRND – Get Free Report) saw a large increase in short interest during the month of October. As...
Short Interest in Hims & Hers Health, Inc. (NYSE:HIMS) Rises By 6.2%
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) saw a large increase in short interest in the month...
Abitibi Royalties (CVE:RZZ) Shares Down 0.6% – Here’s What Happened
Abitibi Royalties Inc. (CVE:RZZ – Get Free Report) shares fell 0.6% on Monday . The company traded as low as...